Goldman Sachs’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,900
Closed -$1.15M 6742
2021
Q3
$1.15M Hold
10,900
﹤0.01% 4633
2021
Q2
$1.93M Hold
10,900
﹤0.01% 4230
2021
Q1
$1.45M Buy
+10,900
New +$1.69M ﹤0.01% 4303
2020
Q4
Sell
-42,100
Closed -$3.5M 5745
2020
Q3
$3.5M Hold
42,100
﹤0.01% 3167
2020
Q2
$3.46M Buy
+42,100
New +$2.85M ﹤0.01% 3058

Other funds holding ZLAB

Goldman Sachs's ZLAB Position: Q1 2026 in Review

Goldman Sachs reduced its Zai Lab (ZLAB) stake by 26% in Q1 2026, selling an estimated $720K and leaving 110,587 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4508.

Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 32 quarters since. The position peaked at $87.8M in Q3 2020. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • Goldman Sachs held 110,587 shares of Zai Lab worth $2.08M as of Q1 2026.
  • Goldman Sachs sold 38,847 Zai Lab shares in Q1 2026, an estimated $720K.
  • Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4508 holding.
  • Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 32 quarters since.
  • Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.